Global Codeine Tablet Market Research Report 2023

Publication ID:

PB510241287

Publication Date:

October 11, 2023

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Codeine Tablet market is projected to reach US$ 1266.7 million in 2029, increasing from US$ 852 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Codeine Tablet 91制片厂.
The Codeine Tablet market has evolved as a prescription medication used to manage pain and suppress coughing. Codeine is an opioid analgesic that works by affecting the brain's perception of pain and reducing the brain's response to coughing signals. These tablets are prescribed for mild to moderate pain relief and non-productive cough suppression. As part of the broader opioid medication class, the Codeine Tablet market is subject to regulations and guidelines aimed at ensuring responsible use to prevent misuse and dependency. Despite concerns about opioid-related issues, the market continues to address specific medical needs while emphasizing proper medical supervision and patient education regarding potential risks and benefits.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Codeine Tablet market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Codeine Tablet report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Codeine Tablet Market Overview
1.1 Product Overview and Scope of Codeine Tablet
1.2 Codeine Tablet Segment by Type
1.2.1 Global Codeine Tablet Market Value Comparison by Type (2023-2029)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine Tablet Segment by Application
1.3.1 Global Codeine Tablet Market Value by Application: (2023-2029)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Tablet Market Size Estimates and Forecasts
1.4.1 Global Codeine Tablet Revenue 2018-2029
1.4.2 Global Codeine Tablet Sales 2018-2029
1.4.3 Global Codeine Tablet Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Codeine Tablet Market Competition by Manufacturers
2.1 Global Codeine Tablet Sales Market Share by Manufacturers (2018-2023)
2.2 Global Codeine Tablet Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Codeine Tablet Average Price by Manufacturers (2018-2023)
2.4 Global Codeine Tablet Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Codeine Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Codeine Tablet, Product Type & Application
2.7 Codeine Tablet Market Competitive Situation and Trends
2.7.1 Codeine Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Codeine Tablet Players Market Share by Revenue
2.7.3 Global Codeine Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Codeine Tablet Retrospective Market Scenario by Region
3.1 Global Codeine Tablet Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Codeine Tablet Global Codeine Tablet Sales by Region: 2018-2029
3.2.1 Global Codeine Tablet Sales by Region: 2018-2023
3.2.2 Global Codeine Tablet Sales by Region: 2024-2029
3.3 Global Codeine Tablet Global Codeine Tablet Revenue by Region: 2018-2029
3.3.1 Global Codeine Tablet Revenue by Region: 2018-2023
3.3.2 Global Codeine Tablet Revenue by Region: 2024-2029
3.4 North America Codeine Tablet Market Facts & Figures by Country
3.4.1 North America Codeine Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Codeine Tablet Sales by Country (2018-2029)
3.4.3 North America Codeine Tablet Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Codeine Tablet Market Facts & Figures by Country
3.5.1 Europe Codeine Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Codeine Tablet Sales by Country (2018-2029)
3.5.3 Europe Codeine Tablet Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Codeine Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Codeine Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Codeine Tablet Sales by Country (2018-2029)
3.6.3 Asia Pacific Codeine Tablet Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Codeine Tablet Market Facts & Figures by Country
3.7.1 Latin America Codeine Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Codeine Tablet Sales by Country (2018-2029)
3.7.3 Latin America Codeine Tablet Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Codeine Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Codeine Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Codeine Tablet Sales by Country (2018-2029)
3.8.3 Middle East and Africa Codeine Tablet Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Codeine Tablet Sales by Type (2018-2029)
4.1.1 Global Codeine Tablet Sales by Type (2018-2023)
4.1.2 Global Codeine Tablet Sales by Type (2024-2029)
4.1.3 Global Codeine Tablet Sales Market Share by Type (2018-2029)
4.2 Global Codeine Tablet Revenue by Type (2018-2029)
4.2.1 Global Codeine Tablet Revenue by Type (2018-2023)
4.2.2 Global Codeine Tablet Revenue by Type (2024-2029)
4.2.3 Global Codeine Tablet Revenue Market Share by Type (2018-2029)
4.3 Global Codeine Tablet Price by Type (2018-2029)
5 Segment by Application
5.1 Global Codeine Tablet Sales by Application (2018-2029)
5.1.1 Global Codeine Tablet Sales by Application (2018-2023)
5.1.2 Global Codeine Tablet Sales by Application (2024-2029)
5.1.3 Global Codeine Tablet Sales Market Share by Application (2018-2029)
5.2 Global Codeine Tablet Revenue by Application (2018-2029)
5.2.1 Global Codeine Tablet Revenue by Application (2018-2023)
5.2.2 Global Codeine Tablet Revenue by Application (2024-2029)
5.2.3 Global Codeine Tablet Revenue Market Share by Application (2018-2029)
5.3 Global Codeine Tablet Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Corporation Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Taiji Codeine Tablet Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Corporation Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Mallinckrodt Codeine Tablet Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TEVA Codeine Tablet Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Codeine Tablet Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Corporation Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Medreich Codeine Tablet Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Corporation Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanofi Aventis Codeine Tablet Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Codeine Tablet Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Corporation Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hikma Codeine Tablet Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Corporation Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pharmaceutical Associates Codeine Tablet Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis Codeine Tablet Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Codeine Tablet Description and Business Overview
6.11.3 Apotex Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Apotex Codeine Tablet Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Corporation Information
6.12.2 Mylan Codeine Tablet Description and Business Overview
6.12.3 Mylan Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Mylan Codeine Tablet Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Corporation Information
6.13.2 Aristo Pharma GmbH Codeine Tablet Description and Business Overview
6.13.3 Aristo Pharma GmbH Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Aristo Pharma GmbH Codeine Tablet Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Corporation Information
6.14.2 Lannett Company Codeine Tablet Description and Business Overview
6.14.3 Lannett Company Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Lannett Company Codeine Tablet Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Corporation Information
6.15.2 Laboratoire Riva Codeine Tablet Description and Business Overview
6.15.3 Laboratoire Riva Codeine Tablet Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Laboratoire Riva Codeine Tablet Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Codeine Tablet Industry Chain Analysis
7.2 Codeine Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Codeine Tablet Production Mode & Process
7.4 Codeine Tablet Sales and Marketing
7.4.1 Codeine Tablet Sales Channels
7.4.2 Codeine Tablet Distributors
7.5 Codeine Tablet Customers
8 Codeine Tablet Market Dynamics
8.1 Codeine Tablet Industry Trends
8.2 Codeine Tablet Market Drivers
8.3 Codeine Tablet Market Challenges
8.4 Codeine Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.